Online Inquiry
Cat.#: ACPP-1190
| Despition | ADCY6 Blocking Peptide for Immunodepletion, Immunocompetition |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1100 | Synthetic Membrane Nanoparticle Human Somatostatin Receptor 2 Protein (AC1100) | 50 µg | inquiry |
| ACPP-1414 | Human BEX1 Protein (AC1414) | 2 µg | inquiry |
| ACPP-1789 | Human PEDF Protein (AC1789) | 5 µg | inquiry |
| ACPP-1281 | ULK1 Blocking Peptide (AC1281) | 250 µg | inquiry |
| ACPP-1095 | Synthetic Nanodisc Human MLC1 Protein (AC1095) | 10 µg | inquiry |
| ACPP-1097 | Synthetic Nanodisc Human ENTPD2 Protein (AC1097) | 10 µg | inquiry |
| ACPP-1126 | Recombinant Human Peripherin Protein (AC1126) | 25 µl | inquiry |
| ACPP-1522 | Dopamine Receptor D3 Blocking Peptide (AC1522) | 250 µg | inquiry |
| ACPP-1433 | Human Interleukin 6 (Active) Protein (AC1433) | 100 µg | inquiry |
| ACPP-1370 | EFEMP1 Blocking Peptide (AC1370) | 250 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.